|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | -2.03% |
|
+9.85% | -44.66% |
| Apr. 05 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
| Apr. 01 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
Apyx Medical Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 52.35 million compared to USD 44.51 million a year ago. Net loss was USD 18.71 million compared to USD 23.18 million a year ago.
Basic loss per share from continuing operations was USD 0.54 compared to USD 0.67 a year ago. Diluted loss per share from continuing operations was USD 0.54 compared to USD 0.67 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.66% | 50.23M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
APYX MEDICAL CORPORATION 
